Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tandem Diabetes (TNDM) Tops Q1 EPS by 8c, Revenues Beat; Offers FY21 Revenues Guidance Above Consensus
May 5, 2021 4:38 PM EDTTandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.08), $0.08 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $141 million versus the consensus estimate of $121.96 million.
First Quarter 2021 Highlights
In comparing the first quarter of 2021 to the same period of 2020:
Worldwide pump shipments increased 46 percent to 25,352 pumps from 17,378 pumpsSales increased 44 percent to $141.0 million from $97.9 millionGross margin improved to 52 percent of sales from 51 percentOperating margin... More